A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: A pilot study

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 5, 1996, Pages 777-786

  Bernstein, C N ^a   Seeger, L L ^b   Anton, P A ^b   Artinian, L ^b   Geffrey, S ^c   Goodman, W ^b   Belin, T R ^b   Shanahan, F ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CARBONATE; CORTICOSTEROID; ERGOCALCIFEROL; PLACEBO; PREDNISONE;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENTERITIS; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029817443     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.63205000.x     Document Type: Article

References (42)

1. Bernstein CN, Seeger LL, Sayre JW, et al. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995; 10: 250-6.
2. Cummings SR, Black DM, Nevitt, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341: 72-5.
3. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107: 1031-9.
4. Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 417-22.
5. Pigot F, Roux C, Chaussade S, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992; 37: 1396-1403.
6. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28: 410-5.
7. Genant HK, Mall JC, Wagonfeld JB, Vander Horst J, Lanzi LH. Skeletal demineralization and growth retardation in inflammatory bowel disease. Invest Radiol 1976; 11: 541-9.
8. Saville PD, Kharmosh D. Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum 1967; 10: 423-30.
9. Bjelle AO, Nilsson BE. Osteoporosis in rheumatoid arthritis. Calcif Tissue Res 1970; 5: 327-32.
10. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983; 309: 265-8.
11. Ruegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983; 25: 615-20.
12. Compston JE. Review article: Osteoporosis, costicosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995; 9: 237-50.
13. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 1990; 112: 352-64.
14. Marcus R. Exercise and the regulation of bone mass. Arch Int Med 1989; 149: 2170-1.
15. Schechtman KB, Barzilai B, Rost K, Fisher EB. Measuring physical activity with a single question. Am J Public Health 1991; 81: 771-3.
16. Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988; 29: 1332-6.
17. Clements D, Motley RJ, Evans WD, et al. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol 1992; 27: 1055-60.
18. Roux C, Abitbol V, Chaussade S, et al. Bone loss in patients with inflammatory bowel disease: A prospective study. Osteoporosis Int 1995; 5: 156-60.
19. Hahn TJ, Halstead LR, Baran DT. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol 1981; 52: 111-5.
20. Morris HA, Need AG, O'Loughlin PD, et al. Malabsorption of calcium in corticosteroid-induced osteoporosis. Calcif Tissue Int 1990; 46: 305-8.
21. Gennari C. Differential effect of glucocorticoids on calcium absorption and bone mass. Br J Rheum 1993; 32(Suppl. 2): 11-4.
22. Heaney RP. Lifelong calcium intake and prevention of bone fragility in the aged. Calcif Tissue Int 1991; 49(Suppl.): S42-S45.
23. Bauer DC, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women. Ann Intern Med 1993; 118: 657-65.
24. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993; 328: 460-4.
25. Dawson-Hughes B, Dallal GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323: 878-83.
26. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med 1991; 325: 1189-95.
27. Cumming RG. Calcium and bone mass: A quantitative review of the evidence. Calcif Tissue Int 1990; 47: 194-201.
28. Baran D, Sorensen A, Grimes J, et al. Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: A three-year prospective study. J Clin Endocrinol Metab 1990; 70: 264-70.
29. Kanders B, Dempster DW, Lindsay R. Interaction of calcium nutrition and physical activity on bone mass in young women. J Bone Mineral Res 1988; 3: 145-9.
30. Picard D, Ste-Marie LG, Coutu D, et al. Premenopausal bone mineral content relates to height, weight and calcium intake during early adulthood. Bone Miner 1988; 4: 299-309.
31. Compston JE, Ryde SJS, Motley RJ, Crawley EO, Evans WD, Morgan WD. Longitudinal study of total body calcium measurements in patients with inflammatory bowel disease: Correlations with quantitative CT and single photon absorptiometry. In: Yasumura S, ed. Advances In In Vivo Body Composition Studies. New York: Plenum Press, 1990: 75-8.
32. Reid IR, Ibbertson HK. Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 1986; 44: 287-90.
33. Vogelsang H, Ferenci P, Woloszczuk W, et al. Bone disease in vitamin D deficient patients with Crohn's disease. Dig Dis Sci 1989; 34: 1094-9.
34. Klein RG, Arnaud SB, Gallagher JC, DeLuca HF, Riggs BL. Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest 1977; 60: 253-9.
35. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest 1979; 64: 655-65.
36. Dykman TR, Haralson KM, Gluck OS, et al. Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1984; 27: 1336-43.
37. Biljsma JWJ, Raymakers JA, Mosch C, et al. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exper Rheumatol 1988; 6: 113-9.
38. Rickers H, Deding AA, Christiansen C, Rodbro P. Mineral loss in cortical and trabecular bone during high-dose prednisone treatment. Calcif Tissue Int 1984; 36: 269-73.
39. Vogelsang H, Ferenci P, Resch H, Kiss A, Woloszczuk W, Gangl A. Randomized controlled trial of longterm vitamin D supplementation in patients with Crohn's disease. Gastroenterology 1991; 100: A260(Abstract).
40. Dunne WT, Cooke WT, Allan RN. Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract. Gut 1977; 18: 290-4.
41. Bernstein CN, Ament M, Artinian L, Ridgeway J, Shanahan F. Milk tolerance in adults with ulcerative colitis. Am J Gastroenterol 1994; 89: 872-7.
42. Lindsay R. Prevention and treatment of osteoporosis. Lancet 1993; 341: 801-5.